Financial Litigation - Page 7 of 10 - Fideres

What Pharmacy Benefit Managers Don’t Want You to Know

Payment flow and pricing structure are highly complex and nontransparent within the US pharmaceutical industry. No single entity having a

February 10, 2017

Fideres Mentioned In Bloomberg Article On Currency Derivatives

Bloomberg published an article today about how mis-selling of currency derivatives are being exposed, especially in the aftermath of Brexit.

August 30, 2016

Indexers in Hiding: Active Funds That Aren’t So Active

Active share alone can give a biased view of funds’ activeness. Other metrics must be considered alongside active share to

U.S. Class Action Alleges Conspiracy In The SSA Bond Market

Labaton and Hausfeld have filed a class action in the U.S. alleging a conspiracy in the Supranational, Sub-sovereign and Agency

Fideres Research On Corporate Bond Pricing Widely Reported

Fideres research has been reported on by Bloomberg, Reuters and a number of other news organisations. The research found evidence

Why Corporations May Be Paying Too Much To Borrow

Fideres analyzed the pricing of new corporate bond issuances between 2010 and 2015. We found that, on average, bonds are

Interest Rate Swaps and the Collusion Allegations Rocking the Market

Users of the IRS markets fail to benefit from cost reducing liquidity post SEFs. First of class action suits filed. Collusion

November 30, 2015

U.S. Class Action Complaint Alleges IRS Fixing

The latest class action complaint filed by Quinn Emanuel in the Southern District of New York on November 25, 2015

November 26, 2015

LIBOR’s Legacy: Competition Issues Still Haunt Benchmarks

Fideres has conducted original research into how USD LIBOR panel members consistently extracted monopoly rents. For 2009, these monopoly rents

November 11, 2015

Can Bond Rigging Happen In Europe?

30 class actions have been filed in the US alleging manipulation of the auction facility used to issue new US

October 21, 2015